Modern treatment in chronic lymphocytic leukemia: impact on survival and efficacy in high-risk subgroups
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Modern treatment in chronic lymphocytic leukemia: impact on survival and efficacy in high-risk subgroups
Authors
Keywords
-
Journal
Cancer Medicine
Volume 3, Issue 3, Pages 555-564
Publisher
Wiley
Online
2014-03-19
DOI
10.1002/cam4.226
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients
- (2015) Gian Matteo Rigolin et al. Oncotarget
- Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions
- (2014) Valentin Goede et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chronic lymphocytic leukemia: 2013 update on diagnosis, risk stratification and treatment
- (2013) Michael Hallek AMERICAN JOURNAL OF HEMATOLOGY
- The combination of rituximab, bendamustine, and cytarabine for heavily pretreated relapsed/refractory cytogenetically high-risk patients with chronic lymphocytic leukemia
- (2013) Carlo Visco et al. AMERICAN JOURNAL OF HEMATOLOGY
- Signaling the end of chronic lymphocytic leukemia: new frontline treatment strategies
- (2013) M. Hallek BLOOD
- TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial
- (2013) P. Dreger et al. BLOOD
- Long-term repair of T-cell synapse activity in a phase II trial of chemoimmunotherapy followed by lenalidomide consolidation in previously untreated chronic lymphocytic leukemia (CLL)
- (2013) T. D. Shanafelt et al. BLOOD
- Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia
- (2013) Dan A. Landau et al. CELL
- Clinical implications of the molecular genetics of chronic lymphocytic leukemia
- (2013) R. Foa et al. HAEMATOLOGICA
- Chronic lymphocytic leukemia in young (
- (2013) S. A. Parikh et al. HAEMATOLOGICA
- The unequal health of Europeans: successes and failures of policies
- (2013) Johan P Mackenbach et al. LANCET
- Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial
- (2013) Susan O'Brien et al. LANCET ONCOLOGY
- Prediction of poor outcome in CLL patients following first-line treatment with fludarabine, cyclophosphamide and rituximab
- (2013) A M Fink et al. LEUKEMIA
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- A Mechanism-Driven Treatment for Chronic Lymphocytic Leukemia?
- (2013) Robin Foà et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
- (2013) John C. Byrd et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost of illness and economic burden of chronic lymphocytic leukemia
- (2013) Carl Rudolf Blankart et al. Orphanet Journal of Rare Diseases
- Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: correlations with clinicobiologic parameters
- (2012) G. M. Rigolin et al. BLOOD
- Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia
- (2012) D. Rossi et al. BLOOD
- The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial
- (2012) D. G. Oscier et al. BLOOD
- Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer
- (2012) A. G. Ramsay et al. BLOOD
- Molecular pathogenesis of chronic lymphocytic leukemia
- (2012) Gianluca Gaidano et al. JOURNAL OF CLINICAL INVESTIGATION
- Bendamustine in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group
- (2012) Kirsten Fischer et al. JOURNAL OF CLINICAL ONCOLOGY
- Biallelic ATM Inactivation Significantly Reduces Survival in Patients Treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 Trial
- (2012) Anna Skowronska et al. JOURNAL OF CLINICAL ONCOLOGY
- Alemtuzumab in Combination With Methylprednisolone Is a Highly Effective Induction Regimen for Patients With Chronic Lymphocytic Leukemia and Deletion of TP53: Final Results of the National Cancer Research Institute CLL206 Trial
- (2012) Andrew R. Pettitt et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of Age on Outcomes After Initial Therapy With Chemotherapy and Different Chemoimmunotherapy Regimens in Patients With Chronic Lymphocytic Leukemia: Results of Sequential Cancer and Leukemia Group B Studies
- (2012) Jennifer A. Woyach et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Lenalidomide and Rituximab As Salvage Therapy for Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
- (2012) Xavier C. Badoux et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcome of patients with relapsed or refractory chronic lymphocytic leukemia treated with flavopiridol: impact of genetic features
- (2012) J A Woyach et al. LEUKEMIA
- Frontline chemoimmunotherapy with fludarabine, cyclophosphamide, alemtuzumab, and rituximab for high-risk chronic lymphocytic leukemia
- (2011) S. A. Parikh et al. BLOOD
- Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL
- (2011) X. C. Badoux et al. BLOOD
- The phosphoinositide 3'-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia
- (2011) J. Hoellenriegel et al. BLOOD
- Bendamustine Combined With Rituximab in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group
- (2011) Kirsten Fischer et al. JOURNAL OF CLINICAL ONCOLOGY
- Delivering affordable cancer care in high-income countries
- (2011) Richard Sullivan et al. LANCET ONCOLOGY
- Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays
- (2011) M Ciccone et al. LEUKEMIA
- Evidence-Based Mini-Review: The Role of Alkylating Agents in the Initial Treatment of Chronic Lymphocytic Leukemia Patients with the 11q Deletion
- (2011) W. Ding et al. Hematology-American Society of Hematology Education Program
- Nurture versus Nature: The Microenvironment in Chronic Lymphocytic Leukemia
- (2011) J. A. Burger Hematology-American Society of Hematology Education Program
- Using the Biology of Chronic Lymphocytic Leukemia to Choose Treatment
- (2011) P. Hillmen Hematology-American Society of Hematology Education Program
- Moving from prognostic to predictive factors in chronic lymphocytic leukaemia (CLL)
- (2010) Thorsten Zenz et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Circulating endothelial cells in patients with chronic lymphocytic leukemia
- (2010) Gian Matteo Rigolin et al. CANCER
- Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia
- (2010) Tait D. Shanafelt et al. CANCER
- Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation
- (2010) D. Oscier et al. HAEMATOLOGICA
- Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia
- (2010) William G. Wierda et al. JOURNAL OF CLINICAL ONCOLOGY
- Rituximab Plus Fludarabine and Cyclophosphamide Prolongs Progression-Free Survival Compared With Fludarabine and Cyclophosphamide Alone in Previously Treated Chronic Lymphocytic Leukemia
- (2010) Tadeusz Robak et al. JOURNAL OF CLINICAL ONCOLOGY
- Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
- (2010) M Hallek et al. LANCET
- Improving survival in patients with chronic lymphocytic leukemia (1980-2008): the Hospital Clinic of Barcelona experience
- (2009) P. Abrisqueta et al. BLOOD
- First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia
- (2009) B. F. Eichhorst et al. BLOOD
- De novo deletion 17p13.1 chronic lymphocytic leukemia shows significant clinical heterogeneity: the M. D. Anderson and Mayo Clinic experience
- (2009) C. S. Tam et al. BLOOD
- Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway
- (2009) R. Lapalombella et al. BLOOD
- Chemoimmunotherapy may overcome the adverse prognostic significance of 11q deletion in previously untreated patients with chronic lymphocytic leukemia
- (2009) Apostolia-Maria Tsimberidou et al. CANCER
- Improved survival in chronic lymphocytic leukemia in the past decade: a population-based study including 11,179 patients diagnosed between 1973-2003 in Sweden
- (2009) S. Y. Kristinsson et al. HAEMATOLOGICA
- 5-Year Survival in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia in a Randomized, Phase III Trial of Fludarabine Plus Cyclophosphamide With or Without Oblimersen
- (2009) Susan O'Brien et al. JOURNAL OF CLINICAL ONCOLOGY
- Rituximab, Fludarabine, Cyclophosphamide, and Mitoxantrone: A New, Highly Active Chemoimmunotherapy Regimen for Chronic Lymphocytic Leukemia
- (2009) Francesc Bosch et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinicobiologic importance of cytogenetic lesions in chronic lymphocytic leukemia
- (2009) Francesco Cavazzini et al. Expert Review of Hematology
- Predicting clinical outcome in CLL: how and why
- (2009) T. D. Shanafelt Hematology-American Society of Hematology Education Program
- Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century
- (2008) H. Brenner et al. BLOOD
- Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia
- (2008) C. S. Tam et al. BLOOD
- miR-34a as part of the resistance network in chronic lymphocytic leukemia
- (2008) T. Zenz et al. BLOOD
- Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis
- (2008) Francesco Cavazzini et al. BRITISH JOURNAL OF HAEMATOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started